Morningside Venture Investments Limited 13D/13G Filings for Atea Pharmaceuticals, Inc. (AVIR)

Morningside Venture Investments Limited 13D and 13G filings for Atea Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-16
4:00 pm
Sale
2021-12-3113GATEA PHARMACEUTICALS INC
AVIR
Morningside Venture Investments Limited0
0.000%
-19,495,148decrease
(Position Closed)
Filing
2022-02-14
4:18 pm
Purchase
2021-12-3113GATEA PHARMACEUTICALS INC
AVIR
Morningside Venture Investments Limited19,495,148
40.900%
12,860,192increase
(+193.82%)
Filing